glp-1

Latest news and analysis on glp-1

Equities

Ozempic first mover sheds $170B in 4 days: Here's 2 ideas we're backing instead

After crashing more than 30% this week, Novo Nordisk has now seen its share price fall 65% over the last 12 months.
+1
Arms Rosenberg
Minotaur Capital
1